Evaluation of patient adherence with oral anticancer agents

被引:0
|
作者
Kazaz, Seher Nazli [1 ]
Yildirim, Atila [1 ]
机构
[1] Karadeniz Tech Univ, Sch Med, Dept Med Oncol, Trabzon, Turkiye
关键词
Adherence; cancer; modified medication adherence scale-6; modified morisky scale; oral anticancer drugs; MEDICATION ADHERENCE; THERAPY; OUTCOMES; INTERVENTIONS; NONADHERENCE; MANAGEMENT; DURATION; IMATINIB;
D O I
10.4103/jcrt.jcrt_2238_22
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background:The aim of the study was to measure the adherence to oral anticancer treatments in cancer patients using the Modified Morisky Scale (Modified Medication Adherence Scale 6) which has been shown to be valid and reliable in Turkish. Methods:This study was an observational, single-center study involving 300 cancer patients receiving various oral anticancer agents admitted to our outpatient clinic. Motivation and knowledge scores were calculated as per the Modified Medication Adherence Scale 6. Results:The motivation and knowledge levels of the population aged less than 65 years were found to be significantly higher than the geriatric population (>= 65 years old) (P < .003 and P< .001, respectively). It was observed that the patients with higher education levels had significantly higher motivation and knowledge levels (P < .0001 for both). There was no correlation between the motivation and knowledge levels of the patients with gender, marital status, living status, and stage of the disease (P > .05). In addition, the duration of drug use >12 months and the cyclical use of drugs were also found to be significantly associated with increased motivation and knowledge levels. Conclusion:Identifying adherence and related factors, informing patients in detail about the efficacy and toxicity of treatments are the simplest and most basic methods. Particular attention should be paid to patients aged > 65 years, patients with a low level of education, and patients in the earlier stages of their treatments.
引用
收藏
页码:1707 / 1712
页数:6
相关论文
共 50 条
  • [11] Oral Anticancer Agents An intervention to promote medication adherence and symptom management
    Spoelstra, Sandra L.
    Sikorskii, Alla
    Majumder, Atreyee
    Burhenn, Peggy S.
    Schueller, Monica
    Given, Barbara
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2017, 21 (02) : 157 - 160
  • [12] Adherence and awareness of the therapeutic intent of oral anticancer agents in an outpatient setting
    Kimura, Michio
    Nakashima, Keiji
    Usami, Eiseki
    Iwai, Mina
    Nakao, Toshiya
    Yoshimura, Tomoaki
    Mori, Hiromi
    Teramachi, Hitomi
    ONCOLOGY LETTERS, 2015, 9 (05) : 2341 - 2346
  • [13] Adherence to Oral Anticancer Agents Among Adults With Gastrointestinal Tract Cancer
    Chen, Yongfeng
    Ng, Marques Shek Nam
    Zhang, Mengyue
    Chan, Carmen Wing Han
    CANCER NURSING, 2025,
  • [14] PATIENT ADHERENCE TO ORAL ANTICANCER DRUGS: AN EMERGING ISSUE IN MODERN ONCOLOGY
    Foulon, V
    Schoeffski, P.
    Wolter, P.
    ACTA CLINICA BELGICA, 2011, 66 (02) : 85 - 96
  • [15] Optimizing Adherence to Oral Anticancer Agents: Results from an Implementation Mapping Study
    Muluneh, Benyam
    Upchurch, Maurlia
    Mackler, Emily
    Bryant, Ashley Leak
    Wood, William A.
    Wheeler, Stephanie B.
    Zullig, Leah L.
    Lafata, Jennifer Elston
    CURRENT ONCOLOGY, 2025, 32 (02)
  • [16] Side Effects, Self-Management Activities, and Adherence to Oral Anticancer Agents
    Jiang, Yun
    Wickersham, Karen E.
    Zhang, Xingyu
    Barton, Debra L.
    Farris, Karen B.
    Krauss, John C.
    Harris, Marcelline R.
    PATIENT PREFERENCE AND ADHERENCE, 2019, 13 : 2243 - 2252
  • [17] Adherence influencing factors in patients taking oral anticancer agents: A systematic review
    Mathes, Tim
    Pieper, Dawid
    Antoine, Sunya-Lee
    Eikermann, Michaela
    CANCER EPIDEMIOLOGY, 2014, 38 (03) : 214 - 226
  • [18] ADHERENCE TO ORAL ANTINEOPLASTIC AGENTS IN A DIVERSE PATIENT POPULATION.
    Ellsworth-Wolk, Jean
    Dunson, Susan
    Thoman, Barbara
    O'Reilly, Patricia
    Smekar, Mary
    Siedlecki, Sandra
    ONCOLOGY NURSING FORUM, 2015, 42 (02) : E233 - E233
  • [19] Leveraging a conversational agentto support adherence to oral anticancer agents:A usability study.
    Berges, Bethany Mooney
    Cambareri, Christine
    Takvorian, Samuel U.
    Serpa, Mike
    Shulman, Lawrence N.
    Bekelman, Justin E.
    Rendle, Katharine A.
    Argon, Jesse
    Rosin, Roy
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [20] Impact of initiating oral anticancer agents for leukemia on adherence to medications for multiple chronic conditions
    Gatwood, Justin
    Dashputre, Ankur
    Rajpurohit, Abhijeet
    Gatwood, Katie
    Mackler, Emily
    Wallace, Leah
    Farris, Karen
    Rizvi-Toner, Amna
    Farley, Joel
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (02) : 342 - 353